Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
B-Raf and c-Raf inhibitor.
Cannabinoid receptor 2 selective agonist.
Tyrphostin; VEGFR inhibitor.
A probe for cholesterol in biological membranes...
B-Raf and c-Raf inhibitor.
Statin; HMG-CoA reductase inhibitor.
Vitamin D2, ergocalciferol metabolite; VDR agon...
Inhibitor of CDK.
Derivative of methyl caffeate, hydroxycinnamic ...
Nucleoside (deoxyadenosine) analog found in Co...
p110δ and p110γ PI3K inhibitor.
Synthetic glycolipid found in Agelas mauritaniu...
Aspirin analog; hemoglobin chain cross-linker.<...
5-Nitroimidazole derivative; genotoxic.
Non-selective HDAC inhibitor.
Sesquiterpene lactone found in Artemisia (wormw...
Sesquiterpene lactone found in Ginkgo; GABA-A a...
Vitamin B1
Macrolide; protein translation inhibitor.
Synthetic antifungal.